abrdn plc Decreases Stock Position in DaVita Inc. (NYSE:DVA)

abrdn plc cut its holdings in DaVita Inc. (NYSE:DVA) by 3.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 182,673 shares of the company’s stock after selling 6,392 shares during the period. abrdn plc owned about 0.22% of DaVita worth $27,290,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in DVA. Transcendent Capital Group LLC acquired a new position in DaVita in the 3rd quarter valued at about $25,000. Blue Trust Inc. increased its stake in shares of DaVita by 56.4% during the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company’s stock valued at $54,000 after acquiring an additional 119 shares during the last quarter. Quarry LP acquired a new position in shares of DaVita during the 3rd quarter valued at about $60,000. Versant Capital Management Inc increased its stake in shares of DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after acquiring an additional 169 shares during the last quarter. Finally, ORG Wealth Partners LLC acquired a new position in shares of DaVita during the 3rd quarter valued at about $97,000. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Barclays upped their price objective on shares of DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, DaVita presently has a consensus rating of “Hold” and an average target price of $161.80.

DaVita Stock Performance

DaVita stock opened at $176.85 on Thursday. The stock has a market cap of $14.50 billion, a P/E ratio of 19.08, a price-to-earnings-growth ratio of 0.86 and a beta of 0.93. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78. The stock has a 50 day moving average of $160.33 and a 200-day moving average of $155.99. DaVita Inc. has a 52 week low of $108.76 and a 52 week high of $179.60.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.